Literature DB >> 25104610

Human FGF1 promoter is active in ependymal cells and dopaminergic neurons in the brains of F1B-GFP transgenic mice.

Mei-Shu Chen1, Hua-Kuo Lin, Hsun Chiu, Don-Ching Lee, Yu-Fen Chung, Ing-Ming Chiu.   

Abstract

FGF1 is involved in multiple biological functions and exhibits the importance in neuroprotective effects. Our previous studies indicated that, in human brain and retina, the FGF1B promoter controlled the expression of FGF1. However, the exact function and regulation of FGF1 in brain is still unclear. Here, we generated F1B-GFP transgenic mice that expressed the GFP reporter gene under the control of human FGF1B promoter (-540 to +31). Using the fresh brain sections of F1B-GFP transgenic mice, we found that the F1B-GFP cells expressed strong fluorescent signals in the ventricular system throughout the brain. The results of immunohistochemistry further showed that two distinct populations of F1B-GFP(+) cells existed in the brains of F1B-GFP transgenic mice. We demonstrated that one population of F1B-GFP(+) cells was ependymal cells, which distributed along the entire ventricles, and the second population of F1B-GFP(+) cells was neuronal cells that projected their long processes into multiple directions in specific areas of the brain. The double labeling of F1B-GFP(+) cells and tyrosine hydroxylase indicated that a subpopulation of F1B-GFP(+) -neuronal cells was dopaminergic neurons. Importantly, these F1B-GFP(+) /TH(+) cells were distributed in the main dopaminergic neuronal groups including hypothalamus, ventral tegmental area, and raphe nuclei. These results suggested that human FGF1B promoter was active in ependymal cells, neurons, and a portion of dopaminergic neurons. Thus, the F1B-GFP transgenic mice provide an animal model not only for studying FGF1 gene expression in vivo but also for understanding the role of FGF1 contribution in neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease.
© 2014 The Authors Developmental Neurobiology Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  FGF1; adult brain; dopaminergic neurons; human FGF1 promoter; transgenic mice

Mesh:

Substances:

Year:  2014        PMID: 25104610     DOI: 10.1002/dneu.22225

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  5 in total

Review 1.  FGF1 - a new weapon to control type 2 diabetes mellitus.

Authors:  Emanuel Gasser; Christopher P Moutos; Michael Downes; Ronald M Evans
Journal:  Nat Rev Endocrinol       Date:  2017-06-30       Impact factor: 43.330

2.  FGF1 protects neuroblastoma SH-SY5Y cells from p53-dependent apoptosis through an intracrine pathway regulated by FGF1 phosphorylation.

Authors:  Caroline Pirou; Fatemeh Montazer-Torbati; Nadège Jah; Elisabeth Delmas; Christelle Lasbleiz; Bernard Mignotte; Flore Renaud
Journal:  Cell Death Dis       Date:  2017-08-31       Impact factor: 8.469

3.  A Tri-fusion Reporter Mouse Reveals Tissue-Specific FGF1B Promoter Activity in vivo.

Authors:  Shan-Wen Liu; Ching-Han Hsu; Mei-Ru Chen; Ing-Ming Chiu; Kurt M Lin
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

4.  Stem Cell Therapy for Spinal Cord Injury.

Authors:  Liyi Huang; Chenying Fu; Feng Xiong; Chengqi He; Quan Wei
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

5.  Human IL12p80 Promotes Murine Oligodendrocyte Differentiation to Repair Nerve Injury.

Authors:  Yu-Fen Chung; Jong-Hang Chen; Ching-Wen Li; Hui-Yu Hsu; Ya-Ping Chen; Chiao-Chan Wang; Ing-Ming Chiu
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.